Cross-protective efficacy of immuno-stimulatory recombinant Brugia malayi protein HSP60 against the Leishmania donovani in BALB/c mice.
Brugia malayi
Leishmania donovani
Leishmania-filaria coinfection
Th1 and Th2 immune response
Journal
Biologicals : journal of the International Association of Biological Standardization
ISSN: 1095-8320
Titre abrégé: Biologicals
Pays: England
ID NLM: 9004494
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
07
10
2020
revised:
08
06
2021
accepted:
10
06
2021
pubmed:
8
7
2021
medline:
24
11
2021
entrez:
7
7
2021
Statut:
ppublish
Résumé
Coinfection of Leishmania with bacteria, viruses, protozoans, and nematodes alter the immune system of the host, thereby influencing the disease outcomes. Here, we have determined the immunogenic property and protective efficacy of the cross-reactive molecule HSP60 of filarial parasite B. malayi against the L. donovani in BALB/c mice. Parasitological parameters results showed a significant decrease in the parasite burden (~59%; P < 0.001) and also a substantial increase in the delayed-type hypersensitivity (DTH) response (P < 0.001) in mice immunized with 10 μg of rBmHSP60. Protection against L. donovani in mice immunized with rBmHSP60 resulted from activation of the T cells, which is characterized by higher levels of nitric oxide (NO) production, enhanced cell proliferation, higher levels (expression and release) of IFN- γ, TNF- α, and IL-12, also, higher production of IgG and IgG2a antibodies. This strong Th1 immune response creates an inflammatory domain for L. donovani and protects the host from VL.
Identifiants
pubmed: 34229924
pii: S1045-1056(21)00056-7
doi: 10.1016/j.biologicals.2021.06.001
pii:
doi:
Substances chimiques
Chaperonin 60
0
Cytokines
0
Helminth Proteins
0
Recombinant Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
18-26Informations de copyright
Copyright © 2021 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.